Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Kidney International

• Publication date

  1988-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1038/KI.1988.96PMID 3392886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.

  1987cited by this paper
• The interaction of parathyroid hormone and aluminum in renal osteodystrophy.

  1987cited by this paper
• "High-dose" calcitriol for control of renal osteodystrophy in children on CAPD.

  1987cited by this paper
• Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to the use of deferoxamine.

  1986cited by this paper
• The natural course of dialysis osteomalacia.

  1986cited by this paper
• Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.

  1986cited by this paper
• Aluminum‐associated bone disease in chronic renal failure: High prevalence in a long‐term dialysis population

  1986cited by this paper
• Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.

  1986cited by this paper
• Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis.

  1986cited by this paper
• Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamine.

  1986cited by this paper
• Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.

  1986cited by this paper
• Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.

  1985cited by this paper
• Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients.

  1985cited by this paper
• Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure.

  1985cited by this paper
• Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?

  1985cited by this paper
• Renal Osteodystrophy in Children Treated with 1,25‐Dihydroxy‐Cholecalciferol [1,25‐(OH)2D3]: Histologic Bone Studies

  1984cited by this paper
• Prevalence of Various Types of Bone Disease in Dialysis Patients

  1984cited by this paper
• The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure.

  1984cited by this paper
• Renal Osteodystrophy in Children Undergoing Continuous Ambulatory Peritoneal Dialysis

  1984cited by this paper
• Treatment of fracturing renal osteodystrophy by desferrioxamine.

  1983cited by this paper
• Suppression of parathyroid hormone secretion by aluminum.

  1983cited by this paper
• Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.

  1983cited by this paper
• Histological quantitation of aluminum in iliac bone from patients with renal failure.

  1982cited by this paper
• Bone aluminum and histomorphometric features of renal osteodystrophy.

  1982cited by this paper
• Quantitative bone histology in children with chronic renal failure.

  1982cited by this paper
• The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.

  1982cited by this paper
• Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.

  1982cited by this paper
• Aluminum associated bone disease: clinico-pathologic correlation.

  1982cited by this paper
• Early diagnosis of juvenile renal osteodystrophy.

  1980cited by this paper
• Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?

  1980cited by this paper
• Age dependence of serum enzymatic activities (alkaline phosphatase, aspartate aminotransferase, and creatine kinase) in healthy children and adolescents.

  1978cited by this paper
• Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.

  1976cited by this paper
• Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate.

  1976cited by this paper
• Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

  1975cited by this paper
• 1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure.

  1974cited by this paper
• Quantitative histological studies on the pathogenesis of uremic bone disease.

  1974cited by this paper
• Renal osteodystrophy in children on maintenance haemodialysis.

  1973cited by this paper
• Mortality and hardness of local water-supplies.

  1968cited by this paper
• Teeth pigmented by tetracycline.

  1962cited by this paper

• Bone histomorphometry for the diagnosis of renal osteodystrophy - a European consensus statement.

  2025cites this paper
• Time-lapse HR-pQCT reliably assesses and monitors local bone turnover in patients with chronic kidney disease.

  2025cites this paper
• Chromatin accessibility and epigenetic deoxyribose nucleic acid (DNA) modifications in chronic kidney disease (CKD) osteoblasts: a study of bone and osteoblasts from pediatric patients with CKD.

  2024cites this paper
• Chronic kidney disease mineral bone disorder in childhood and young adulthood: a ‘growing’ understanding

  2023cites this paper
• Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis

  2023cites this paper
• Bone Turnover Markers: Basic Biology to Clinical Applications

  2022cites this paper
• Contemporary kidney transplantation has a limited impact on bone microarchitecture

  2022cites this paper
• Bone Disease in Chronic Kidney Disease and Kidney Transplant

  2022cites this paper
• Static HISTOMORPHOMETRY allows for a diagnosis of bone turnover in renal OSTEODYSTROPHY in the absence of tetracycline labels.

  2021cites this paper
• Patterns of renal osteodystrophy one year after kidney transplantation.

  2021cites this paper
• Histomorphometric analysis of bone remodeling

  2020cites this paper
• Vitamin C overload may contribute to systemic oxalosis in children receiving dialysis

  2020cites this paper
• Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race

  2020cites this paper
• OP-NDTJ200215 1..13

  2020cites this paper
• Bone evaluation in paediatric chronic kidney disease: Clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.

  2020cites this paper
• Racial differences in bone histomorphometry in children and young adults treated with dialysis.

  2019cites this paper
• Establishment of a new murine CKD-MBD model and the role of autophagy in uremic vascular media calcification

  2018cites this paper
• Chronic kidney disease in children

  2016cites this paper
• Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings

  2014cites this paper
• Osteoporosis in Childhood and Adolescence

  2013cites this paper
• Efeito do carbonato de cálcio e do carbonato de sevelamer na remodelação óssea e na calcificação arterial em um modelo experimental de uremia com doença óssea adinâmica

  2013cites this paper
• Chronic kidney disease: mineral and bone disorder in children.

  2013cites this paper
• Diagnosis and Management of Renal Osteodystrophy in Children

  2012cites this paper
• The consequences of chronic kidney disease on bone metabolism and growth in children.

  2012cites this paper
• Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder

  2012cites this paper
• Chronic kidney disease–mineral bone disorders in diabetic kidney disease

  2012cites this paper
• Chronic Kidney Disease Mineral and Bone Disorder

  2012cites this paper
• Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease

  2011cites this paper
• Chronic kidney disease – mineral bone disorders and bone biopsy results in children with chronic kidney disease

  2011influential citation
• Cochrane review: Interventions for bone disease in children with chronic kidney disease

  2011cites this paper
• Post-renal transplantation hypophosphatemia

  2010cites this paper
• Value of the new bone classification system in pediatric renal osteodystrophy.

  2010cites this paper
• The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

  2010cites this paper
• Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium

  2010influential citation
• Interventions for bone disease in children with chronic kidney disease.

  2010cites this paper
• Peritoneal Dialysis in Children

  2009cites this paper
• Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols

  2009cites this paper
• Role of bone biopsy in renal osteodystrophy.

  2009cites this paper
• Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.

  2009cites this paper
• Bone histomorphometry in children prior to commencing renal replacement therapy

  2008cites this paper
• Technical approach to iliac crest biopsy.

  2008cites this paper
• Renal Osteodystrophy: Pathogenic Mechanisms and Therapeutic Options

  2008cites this paper
• Adynamic bone disease—bone and beyond

  2008cites this paper
• Histomorphometric measurements of bone turnover, mineralization, and volume.

  2008cites this paper
• Chronic kidney disease mineral and bone disorder in children

  2007cites this paper
• Bone health and vascular calcification relationships in chronic kidney disease

  2007influential citation
• A structural approach to the assessment of fracture risk in children and adolescents with chronic kidney disease

  2007cites this paper
• New aspects of treatment of renal bone disease in dialysis patients.

  2007cites this paper
• Prevalence of Secondary Hyper Parathyroidism in Hemodialysis Patients

  2007cites this paper
• Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?

  2007cites this paper
• Measurement of Parathyroid Hormone

  2006cites this paper
• PTH(1-84)/PTH(7-84): a balance of power.

  2006cites this paper
• CHAPTER 30 – Measurement of Parathyroid Hormone

  2006cites this paper
• A new era in phosphate binder therapy: what are the options?

  2006cites this paper
• Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic Syndrome.

  2006cites this paper
• Minimizing Bone Abnormalities in Children with Renal Failure

  2006cites this paper
• Are new vitamin D analogues in renal bone disease superior to calcitriol?

  2005cites this paper
• VITAMIN D IN HEALTH AND DISEASE: The Evolution of Assays for Parathyroid Hormone

  2005cites this paper
• VITAMIN D IN HEALTH AND DISEASE: Role of Parathyroid Hormone and Therapy with Active Vitamin D Sterols in Renal Osteodystrophy

  2005cites this paper
• Adynamic bone disease: an update and overview.

  2005cites this paper
• Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.

  2005cites this paper
• New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.

  2005cites this paper
• Biologic Effects of Parathyroid Hormone Metabolites: Implications for Renal Bone Disease

  2004cites this paper
• Hepatitis C in dialysis patients : Relationship to blood transfusions , dialysis and liver disease

  2004cites this paper
• Bone histology in steroid-treated children with non-azotemic nephrotic syndrome

  2004influential citation
• Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy.

  2004cites this paper
• Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy.

  2004influential citation
• New PTH assays and renal osteodystrophy

  2004cites this paper
• Special aspects of renal osteodystrophy in children.

  2004cites this paper
• Secondary Hyperparathyroidism in Children with Chronic Renal Failure

  2003cites this paper
• Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.

  2003cites this paper
• Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.

  2003cites this paper
• Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.

  2003cites this paper
• Bone density measurements in pediatric patients with renal osteodystrophy

  2003cites this paper
• Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.

  2003cites this paper
• Assays for Parathyroid Hormone and Their Use in Patients with End-Stage Renal Disease

  2003cites this paper
• CHAPTER 28 – Renal Osteodystrophy: Pathogenesis, Diagnosis, and Treatment

  2003cites this paper
• Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.

  2003cites this paper
• Biochemical Measurements of Bone Metabolism in Childhood and Adolescence/Biochemische Messungen des Knochenstoffwechsels in Kindheit und Adoleszenz

  2003cites this paper
• Ostéodystrophie rénale: Aspects cliniques, physio- pathologiques et thérapeutiques

  2003cites this paper
• Parathyroid hormone and its fragments in children with chronic renal failure

  2003cites this paper
• Biochemical Markers of Bone Metabolism

  2003cites this paper
• New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.

  2003cites this paper
• Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone

  2003cites this paper
• Growth hormone and the skeleton in pediatric renal allograft recipients

  2002influential citation
• Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women.

  2002cites this paper
• Immunoassays for the detection of parathyroid hormone.

  2002cites this paper
• New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments.

  2002cites this paper
• Cell biology of renal osteodystrophy

  2002cites this paper
• Hyperkalzämie als Folge einer hoch dosierten Vitamin-D-Therapie bei terminaler Niereninsuffizienz

  2002cites this paper
• OSTEODISTROFIA RENAL EN NIÑOS

  2002cites this paper
• Renal osteodystrophy

  2002cites this paper
• CHAPTER 40 – Renal Bone Diseases: Clinical Features, Diagnosis, and Management

  2001cites this paper
• Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.

  2001cites this paper
• CHAPTER 43 – Osteoporosis in Childhood and Adolescence

  2001cites this paper
• Adynamic renal osteodystrophy: is there a problem?

  2001influential citation
• Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.

  2000cites this paper
• [Renal osteodystrophy (3); its treatment in dialysis patients].

  2000cites this paper
• Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism

  2000cites this paper
• Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.

  2000influential citation